Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
clinical trials
3
×
life sciences
national blog main
boston
boston blog main
boston top stories
national top stories
san diego blog main
ally bridge group
alnylam
arena pharmaceuticals
artie suckow
astellas pharma
atlas venture
audentes therapeutics
avidity biosciences
big data analytics
blackrock
bluebird bio
casdin capital
diabetic nephropathy
drug delivery
dtx pharma
duchenne muscular dystrophy
dyne therapeutics
eventide asset management
facioscapulohumeral muscular dystrophy
financing
focal segmental glomerulosclerosis
gene therapy
goldfinch bio
irving investors
jay ghosh
jeff friedman
john grundy
joshua brumm
kaleido biosciences
muscular dystrophy
myotonic dystrophy type 1
What
diseases
3
×
medicines
3
×
drug
genetic
ipo
new
raises
advance
ago
analysis
bio
biologics
biotech
biotechs
bring
company
considered
considering
data
deliver
develop
drugs
dtx
dyne
early
employing
expected
experimental
eyes
goldfinch
having
hitting
humans
ipos
kidney
later
lead
long
million
molecules
Language
unset
Current search:
diseases
×
medicines
×
" clinical trials "
×
@xconomy.com
3 years ago
Dyne Eyes IPO for R&D of Genetic Medicines for Rare Muscle Diseases
@xconomy.com
3 years ago
Goldfinch Raises $100M for Kidney Drug Studies Now, Perhaps an IPO Later
@xconomy.com
4 years ago
DTx Pharma Raises $10.6M to Advance New Way to Deliver RNA Drugs